BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27884335)

  • 1. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
    Grindlinger GA; Cairo SB; Duperre CB
    J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization.
    Driks MR; Craven DE; Celli BR; Manning M; Burke RA; Garvin GM; Kunches LM; Farber HW; Wedel SA; McCabe WR
    N Engl J Med; 1987 Nov; 317(22):1376-82. PubMed ID: 2891032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
    Krag M; Perner A; Wetterslev J; Møller MH
    Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units.
    Eastwood GM; Litton E; Bellomo R; Bailey MJ; Festa M; Beasley RW; Young PJ
    Crit Care Resusc; 2014 Sep; 16(3):170-4. PubMed ID: 25161018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
    Sridharan K; Sivaramakrishnan G; Gnanaraj J
    Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal therapy for stress gastritis.
    Maier RV; Mitchell D; Gentilello L
    Ann Surg; 1994 Sep; 220(3):353-60; discussion 360-3. PubMed ID: 8092901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
    Barkun AN; Adam V; Martel M; Bardou M
    Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
    Cook D; Guyatt G; Marshall J; Leasa D; Fuller H; Hall R; Peters S; Rutledge F; Griffith L; McLellan A; Wood G; Kirby A
    N Engl J Med; 1998 Mar; 338(12):791-7. PubMed ID: 9504939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
    Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
    J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids.
    Bonten MJ; Gaillard CA; van der Geest S; van Tiel FH; Beysens AJ; Smeets HG; Stobberingh EE
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1825-34. PubMed ID: 8520743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
    Zhou JF; Wan XY; Huang W; Han LL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
    ; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
    JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventilator-associated pneumonia and upper airway colonisation with Gram negative bacilli: the role of stress ulcer prophylaxis in children.
    Lopriore E; Markhorst DG; Gemke RJ
    Intensive Care Med; 2002 Jun; 28(6):763-7. PubMed ID: 12107684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
    Song TJ; Kim J
    PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current guidelines on stress ulcer prophylaxis.
    Tryba M; Cook D
    Drugs; 1997 Oct; 54(4):581-96. PubMed ID: 9339962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data.
    Litton E; Eastwood GM; Bellomo R; Beasley R; Bailey MJ; Forbes AB; Gattas DJ; Pilcher DV; Webb SA; McGuinness SP; Saxena MK; McArthur CJ; Young PJ
    Crit Care Resusc; 2014 Sep; 16(3):158-63. PubMed ID: 25161016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of proton pump inhibitors versus histamine-2 receptor blockers in the cardiac surgical population: insights from the PEPTIC trial.
    van Diepen S; Coulson T; Wang X; Opgenorth D; Zuege DJ; Harris J; Agyemang M; Niven DJ; Bellomo R; Wright SE; Young PJ; Bagshaw SM;
    Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35213716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study.
    Bateman BT; Bykov K; Choudhry NK; Schneeweiss S; Gagne JJ; Polinski JM; Franklin JM; Doherty M; Fischer MA; Rassen JA
    BMJ; 2013 Sep; 347():f5416. PubMed ID: 24052582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.